publication date: Dec. 20, 2010

In this issue: 

FDA seeks support for reorganization of cancer programs, but debate continues.

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach.

Duke recruits Judd Moul as chief of urology.

Foundation offers funds for mesothelioma research.

Other NCI funding opportunities listed.

Download (PDF 109KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.